0001192482-19-000502.txt : 20191209
0001192482-19-000502.hdr.sgml : 20191209
20191209184228
ACCESSION NUMBER: 0001192482-19-000502
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191205
FILED AS OF DATE: 20191209
DATE AS OF CHANGE: 20191209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Berelowitz Michael
CENTRAL INDEX KEY: 0001493383
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 191276279
MAIL ADDRESS:
STREET 1: 415 EAST 37TH STREET
STREET 2: APT 36C
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-12-05
0001588972
Recro Pharma, Inc.
REPH
0001493383
Berelowitz Michael
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN,
PA
19355
1
0
0
0
Common Stock
2019-12-05
4
A
0
13848
0
A
41260
D
These restricted stock units will vest in full on the earlier of (i) a change of control of Recro Pharma, Inc. (the "Company") (as defined in the Company's 2018 Amended and Restated Equity Incentive Plan) or (ii) December 5, 2020, subject to continued service with the Company.
/s/ Ryan D. Lake, Attorney-in-fact
2019-12-09